门脉高压
炎症
纤维化
医学
内科学
胎盘生长因子
胃肠病学
肝硬化
血管内皮生长因子
血管内皮生长因子受体
作者
Christophe Van Steenkiste,Jordi Ribera,Anja M. Geerts,Montse Pauta,Sònia Tugues,Christophe R. Casteleyn,Louis J. Libbrecht,Kim Olievier,Ben Schroyen,Hendrik Reynaert,Leo A. van Grunsven,Bram Blomme,Stéphanie Coulon,Femke Heindryckx,Martine De Vos,Jean Marie Stassen,Stefan Vinckier,José Altamirano,Ramon A. Bataller,Peter Carmeliet
出处
期刊:Hepatology
[Lippincott Williams & Wilkins]
日期:2011-02-14
卷期号:53 (5): 1629-1640
被引量:94
摘要
UNLABELLED: Placental growth factor (PlGF) is associated selectively with pathological angiogenesis, and PlGF blockade does not affect the healthy vasculature. Anti-PlGF is therefore currently being clinically evaluated for the treatment of cancer patients. In cirrhosis, hepatic fibrogenesis is accompanied by extensive angiogenesis. In this paper, we evaluated the pathophysiological role of PlGF and the therapeutic potential of anti-PlGF in liver cirrhosis. PlGF was significantly up-regulated in the CCl(4) -induced rodent model of liver cirrhosis as well as in cirrhotic patients. Compared with wild-type animals, cirrhotic PlGF(-/-) mice showed a significant reduction in angiogenesis, arteriogenesis, inflammation, fibrosis, and portal hypertension. Importantly, pharmacological inhibition with anti-PlGF antibodies yielded similar results as genetic loss of PlGF. Notably, PlGF treatment of activated hepatic stellate cells induced sustained extracellular signal-regulated kinase 1/2 phosphorylation, as well as chemotaxis and proliferation, indicating a previously unrecognized profibrogenic role of PlGF. CONCLUSION: PlGF is a disease-candidate gene in liver cirrhosis, and inhibition of PlGF offers a therapeutic alternative with an attractive safety profile.
科研通智能强力驱动
Strongly Powered by AbleSci AI